1.
Shkorik EV. New Immunological Markers of Thromboembolic and Hemorrhagic Complications after Coronary Artery Bypass Grafting. AJP [Internet]. 2018 Feb. 9 [cited 2024 Apr. 28];11(04). Available from: https://www.asiapharmaceutics.info/index.php/ajp/article/view/1748